Q4 2016 13F Holders as of 12/31/2016
-
Type / Class
-
Equity / Common Stock
-
Number of holders
-
67
-
Total shares
-
14.5M
-
Shares change
-
+309K
-
Total reported value, excl. options
-
$71.1M
-
Value change
-
+$201K
-
Put/Call ratio
-
0.67
-
Number of buys
-
32
-
Number of sells
-
-25
-
Price
-
$4.90
Significant Holders of SORRENTO THERAPEUTICS INC - Common Stock (SRNE) as of Q4 2016
68 filings reported holding SRNE - SORRENTO THERAPEUTICS INC - Common Stock as of Q4 2016.
SORRENTO THERAPEUTICS INC - Common Stock (SRNE) has 67 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 14.5M shares
.
Largest 10 shareholders include Wildcat Capital Management, LLC (2.8M shares), Cormorant Asset Management, LLC (1.91M shares), VANGUARD GROUP INC (1.58M shares), venBio Select Advisor LLC (1.46M shares), Intellectus Partners, LLC (1.16M shares), BlackRock Fund Advisors (805K shares), BlackRock Institutional Trust Company, N.A. (652K shares), STATE STREET CORP (515K shares), NORTHERN TRUST CORP (377K shares), and GEODE CAPITAL MANAGEMENT, LLC (353K shares).
This table shows the top 67 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.